Arcturus Therapeutics Holdings Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ARCT, updated each market day.
ARCT AI Sentiment
AI predicts Arcturus Therapeutics Holdings Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Arcturus Therapeutics Holdings Inc. Common Stock
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Sector
Exchange
Market Cap
$233,637,627
Cap Tier
Employees
111
Headquarters
SAN DIEGO, CA
Listed Since
May 22, 2013
Website
ARCT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ARCT Volatility
Arcturus Therapeutics Holdings Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
